As illustrated in Figure 2, the frequency for lymphocytes with asynchronous replication of the AURKA and TP53 genes in the combined group of cancer patients (36.8±4.8 and 28.4±5.1%, respectively) significantly exceed the control levels (22.0±3.4 and 18.0±3.2%, respectively) (p=0.0001). This evidence concerns the gene TP53 and cancer.